Page 140 - MI-2-3
P. 140

Microbes & Immunity                                                   Characterizing low-grade CNS tumors



            and their prognostic and therapeutic relevance, the   Formalin-fixed  tissues  were  processed  with
            present study incorporated Ki-67, MMP-2, VEGFR2,   embedding and sectioned at 10  µm using a microtome
            CD11b, Iba1, and DNMT1 for characterization.       (WESWOX, India). Sections were mounted on glass slides,
                                                               deparaffinized through alcoholic dehydration, stained
              In the present work, we analyzed histopathology and
            molecular hallmarks of three types of low-grade  CNS   with hematoxylin and eosin (Merck, India), and observed
                                                               under a bright field microscope (TS100F Eclipse, Nikon
            tumors: spinal myxopapillary ependymoma, fibroblastic   Corp., Japan). Images were captured using a CCD camera
            meningioma, and diffuse astrocytoma. Low-grade  CNS   (DS-Fi2-U3, Nikon Corp., Japan).
            tumors pose considerable clinical challenges due to
            their unpredictable progression and the lack of reliable   Tumor  type  and  grade  were  determined  by  a
            prognostic biomarkers. Present diagnostic modalities   collaborating pathologist based on histological features,
            often fail to predict which tumors will undergo malignant   following the 2016 WHO classification of CNS tumors.
            transformation, when this transition might occur, and   A total of 10 low-grade tumor samples were obtained: three
            how aggressively the disease may evolve. Consequently,   spinal myxopapillary ependymomas, four fibroblastic
            therapeutic strategies remain suboptimal, adversely   meningiomas, and three diffuse astrocytomas. These
            affecting patient outcomes.                        tumors are frequently underdiagnosed and are typically
                                                               identified only after progression to higher-grade lesions,
              Moreover, the tumor microenvironment and cellular   which limits the number of available samples. Additional
            dynamics that drive progression from indolent to   clinical data included magnetic resonance imaging (MRI)
            aggressive phenotypes remain poorly characterized,   scans with T1-  and T2-weighted contrast-enhanced
            representing a critical knowledge gap in neuro-oncological   imaging  and  magnetic  resonance  spectroscopy  (MRS),
            research. Accordingly, this study aimed to: (i) conduct a   focusing on N-acetylaspartate (NAA) peaks and choline/
            comparative analysis of key molecular ontogenic profiles   creatine ratios. The use of post-operative human tumor
            between  glial  and  non-glial  low-grade  CNS  tumors  to   tissues adhered to ethical guidelines approved by the
            reveal physiological differences; (ii) determine whether   Institutional Ethical Committee, IPGME&R, Kolkata (vide
            these molecular hallmarks represent viable, subtype-  Memo No. Inst/IEC/553, dated January 15, 2014).
            specific therapeutic targets; and (iii) explore whether these
            molecular characterizations could inform the development   2.2. Silver/gold (SG) staining of paraffin-embedded
            of targeted therapies with improved efficacy and reduced   tissue
            off-target toxicity.                               Silver staining and gold toning were performed on
              Although limited by a small sample size, this study   10  µm paraffin-embedded tissue sections. After fixation
            offers a unique contribution to understanding the   and deparaffinization, sections were stained using freshly
            molecular landscape of low-grade  CNS tumors. It may   prepared ammoniacal silver carbonate (CDH, India),
            aid in  diagnosis,  risk  stratification, and  therapeutic   followed by rinsing in 10% formalin.  Subsequently, the
            decision-making. Ultimately, this approach seeks to bridge   sections were toned in gold chloride (Loba Chemie,
            fundamental tumor biology with clinical application,   India) and then fixed in sodium thiosulfate (MERCK,
            offering potential pathways for early intervention strategies   India). Microscopic analysis was carried out using  the
            that could prevent malignant transformation and enable   same imaging system as described in Section 2.1. Images
            more effective targeted therapies.                 were acquired using the NIS Element-BR software (Nikon
                                                               Corp., Japan) to identify electron-dense macrophages and
            2. Methodology                                     microglia.
            2.1. Tumor samples, histology, and metadata        2.3. Tissue preparation for immunofluorescence
            Post-operative CNS tumor tissues were collected from   microscopy
            the Bangur Institute of Neurosciences, Institute of Post   Tissues were fixed in 4% paraformaldehyde (MERCK,
            Graduate Medical Education and Research (IPGME&R),   India), washed, and stored in phosphate-buffered saline
            Kolkata, India. Samples were preserved in (i) 10%   (PBS; CDH, India) at 4°C. Specimens were sectioned at
            buffered formalin (CDH, India) for histopathological and   a thickness of 10 µm, and separate immunofluorescence
            immunohistochemical analysis, (ii) 4% paraformaldehyde   staining protocols were applied using the following
            (MERCK, India) for immunofluorescence studies, and (iii)   antibodies:  glial  fibrillary  acidic  protein  (GFAP)-Alexa
            serum-free Dulbecco’s Modified Eagle Medium (DMEM)   Fluor 488-conjugated monoclonal antibody (mAb) (Cat.
            (Gibco  Invitrogen,  United  States  of  America  [USA])  for   No.  561449, BD Pharmingen, USA), CD11b-FITC mAb
            live cell isolation and flow cytometry.            (Cat. No.  101205, BioLegend, USA), and Iba1 mAb


            Volume 2 Issue 3 (2025)                        132                           doi: 10.36922/MI025190040
   135   136   137   138   139   140   141   142   143   144   145